Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The U.S. Myeloma Forum (USMF) is a non-profit professional organization dedicated to advancing the care of patients with multiple myeloma and related plasma cell disorders. Comprising leading hematologists and oncologists from across the United States, the forum facilitates collaboration, establishes clinical guidelines, and promotes high-impact research. USMF focuses on education, advocacy, and the standardization of treatment protocols to improve patient outcomes nationwide. The organization plays a key role in organizing scientific meetings and providing a platform for expert consensus on emerging therapies and diagnostic tools. By bridging the gap between research and clinical practice, USMF aims to accelerate the delivery of innovative treatments to the myeloma community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on U.S. Myeloma Forum.